Nuclear MYC protein overexpression is an early alteration in human prostate carcinogenesis

Bora Gurel, Tsuyoshi Iwata, Cheryl M. Koh, Robert B. Jenkins, Fusheng Lan, Chi Van Dang, Jessica L. Hicks, James Morgan, Toby C. Cornish, Siobhan Sutcliffe, William B Isaacs, Jun Luo, Angelo Michael Demarzo

Research output: Contribution to journalArticle

Abstract

The MYC onco-protein is a transcription factor that regulates cell proliferation, metabolism, protein synthesis, mitochondrial function and stem cell renewal. A region on chromosome 8q24 encompassing the MYC locus is amplified in prostate cancer, but this occurs mostly in advanced disease suggesting that MYC alterations occur late in prostate cancer. In contrast, MYC mRNA is elevated in most prostate cancers, even those of relatively low stage and grade (eg Gleason score 6) suggesting that MYC plays a role in initiation. However, since MYC protein levels are tightly regulated, elevated MYC mRNA does not necessarily imply elevated MYC protein. Thus, it is critical to determine whether MYC protein is elevated in human prostate cancer, and if so, at what stage of the disease this elevation occurs. Prior studies of MYC protein localization have been hampered by lack of suitable antibodies and controls. We utilized a new anti-MYC antibody coupled with genetically defined control experiments to localize MYC protein within human tissue microarrays consisting of normal, atrophy, PIN, primary adenocarcinoma, and metastatic adenocarcinoma. Nuclear overexpression of MYC protein occurred frequently in luminal cells of PIN, as well as in most primary carcinomas and metastatic disease. MYC protein did not correlate with gain of 8q24, suggesting alternative mechanisms for MYC overexpression. These results provide evidence that upregulation of nuclear MYC protein expression is a highly prevalent and early change in prostate cancer and suggest that increased nuclear MYC may be a critical oncogenic event driving human prostate cancer initiation and progression.

Original languageEnglish (US)
Pages (from-to)1156-1167
Number of pages12
JournalModern Pathology
Volume21
Issue number9
DOIs
StatePublished - Sep 2008

Fingerprint

Nuclear Proteins
Prostate
Carcinogenesis
Prostatic Neoplasms
Proteins
Adenocarcinoma
Messenger RNA
Neoplasm Grading
Mitochondrial Proteins
Atrophy
Anti-Idiotypic Antibodies
Transcription Factors
Up-Regulation
Chromosomes
Cell Proliferation
Carcinoma
Antibodies

Keywords

  • MYC oncoprotein
  • Prostatic carcinoma
  • Prostatic intraepithelial neoplasia

ASJC Scopus subject areas

  • Pathology and Forensic Medicine

Cite this

Nuclear MYC protein overexpression is an early alteration in human prostate carcinogenesis. / Gurel, Bora; Iwata, Tsuyoshi; Koh, Cheryl M.; Jenkins, Robert B.; Lan, Fusheng; Van Dang, Chi; Hicks, Jessica L.; Morgan, James; Cornish, Toby C.; Sutcliffe, Siobhan; Isaacs, William B; Luo, Jun; Demarzo, Angelo Michael.

In: Modern Pathology, Vol. 21, No. 9, 09.2008, p. 1156-1167.

Research output: Contribution to journalArticle

Gurel, B, Iwata, T, Koh, CM, Jenkins, RB, Lan, F, Van Dang, C, Hicks, JL, Morgan, J, Cornish, TC, Sutcliffe, S, Isaacs, WB, Luo, J & Demarzo, AM 2008, 'Nuclear MYC protein overexpression is an early alteration in human prostate carcinogenesis', Modern Pathology, vol. 21, no. 9, pp. 1156-1167. https://doi.org/10.1038/modpathol.2008.111
Gurel, Bora ; Iwata, Tsuyoshi ; Koh, Cheryl M. ; Jenkins, Robert B. ; Lan, Fusheng ; Van Dang, Chi ; Hicks, Jessica L. ; Morgan, James ; Cornish, Toby C. ; Sutcliffe, Siobhan ; Isaacs, William B ; Luo, Jun ; Demarzo, Angelo Michael. / Nuclear MYC protein overexpression is an early alteration in human prostate carcinogenesis. In: Modern Pathology. 2008 ; Vol. 21, No. 9. pp. 1156-1167.
@article{cb27b381905c4ff8b548444c61610030,
title = "Nuclear MYC protein overexpression is an early alteration in human prostate carcinogenesis",
abstract = "The MYC onco-protein is a transcription factor that regulates cell proliferation, metabolism, protein synthesis, mitochondrial function and stem cell renewal. A region on chromosome 8q24 encompassing the MYC locus is amplified in prostate cancer, but this occurs mostly in advanced disease suggesting that MYC alterations occur late in prostate cancer. In contrast, MYC mRNA is elevated in most prostate cancers, even those of relatively low stage and grade (eg Gleason score 6) suggesting that MYC plays a role in initiation. However, since MYC protein levels are tightly regulated, elevated MYC mRNA does not necessarily imply elevated MYC protein. Thus, it is critical to determine whether MYC protein is elevated in human prostate cancer, and if so, at what stage of the disease this elevation occurs. Prior studies of MYC protein localization have been hampered by lack of suitable antibodies and controls. We utilized a new anti-MYC antibody coupled with genetically defined control experiments to localize MYC protein within human tissue microarrays consisting of normal, atrophy, PIN, primary adenocarcinoma, and metastatic adenocarcinoma. Nuclear overexpression of MYC protein occurred frequently in luminal cells of PIN, as well as in most primary carcinomas and metastatic disease. MYC protein did not correlate with gain of 8q24, suggesting alternative mechanisms for MYC overexpression. These results provide evidence that upregulation of nuclear MYC protein expression is a highly prevalent and early change in prostate cancer and suggest that increased nuclear MYC may be a critical oncogenic event driving human prostate cancer initiation and progression.",
keywords = "MYC oncoprotein, Prostatic carcinoma, Prostatic intraepithelial neoplasia",
author = "Bora Gurel and Tsuyoshi Iwata and Koh, {Cheryl M.} and Jenkins, {Robert B.} and Fusheng Lan and {Van Dang}, Chi and Hicks, {Jessica L.} and James Morgan and Cornish, {Toby C.} and Siobhan Sutcliffe and Isaacs, {William B} and Jun Luo and Demarzo, {Angelo Michael}",
year = "2008",
month = "9",
doi = "10.1038/modpathol.2008.111",
language = "English (US)",
volume = "21",
pages = "1156--1167",
journal = "Modern Pathology",
issn = "0893-3952",
publisher = "Nature Publishing Group",
number = "9",

}

TY - JOUR

T1 - Nuclear MYC protein overexpression is an early alteration in human prostate carcinogenesis

AU - Gurel, Bora

AU - Iwata, Tsuyoshi

AU - Koh, Cheryl M.

AU - Jenkins, Robert B.

AU - Lan, Fusheng

AU - Van Dang, Chi

AU - Hicks, Jessica L.

AU - Morgan, James

AU - Cornish, Toby C.

AU - Sutcliffe, Siobhan

AU - Isaacs, William B

AU - Luo, Jun

AU - Demarzo, Angelo Michael

PY - 2008/9

Y1 - 2008/9

N2 - The MYC onco-protein is a transcription factor that regulates cell proliferation, metabolism, protein synthesis, mitochondrial function and stem cell renewal. A region on chromosome 8q24 encompassing the MYC locus is amplified in prostate cancer, but this occurs mostly in advanced disease suggesting that MYC alterations occur late in prostate cancer. In contrast, MYC mRNA is elevated in most prostate cancers, even those of relatively low stage and grade (eg Gleason score 6) suggesting that MYC plays a role in initiation. However, since MYC protein levels are tightly regulated, elevated MYC mRNA does not necessarily imply elevated MYC protein. Thus, it is critical to determine whether MYC protein is elevated in human prostate cancer, and if so, at what stage of the disease this elevation occurs. Prior studies of MYC protein localization have been hampered by lack of suitable antibodies and controls. We utilized a new anti-MYC antibody coupled with genetically defined control experiments to localize MYC protein within human tissue microarrays consisting of normal, atrophy, PIN, primary adenocarcinoma, and metastatic adenocarcinoma. Nuclear overexpression of MYC protein occurred frequently in luminal cells of PIN, as well as in most primary carcinomas and metastatic disease. MYC protein did not correlate with gain of 8q24, suggesting alternative mechanisms for MYC overexpression. These results provide evidence that upregulation of nuclear MYC protein expression is a highly prevalent and early change in prostate cancer and suggest that increased nuclear MYC may be a critical oncogenic event driving human prostate cancer initiation and progression.

AB - The MYC onco-protein is a transcription factor that regulates cell proliferation, metabolism, protein synthesis, mitochondrial function and stem cell renewal. A region on chromosome 8q24 encompassing the MYC locus is amplified in prostate cancer, but this occurs mostly in advanced disease suggesting that MYC alterations occur late in prostate cancer. In contrast, MYC mRNA is elevated in most prostate cancers, even those of relatively low stage and grade (eg Gleason score 6) suggesting that MYC plays a role in initiation. However, since MYC protein levels are tightly regulated, elevated MYC mRNA does not necessarily imply elevated MYC protein. Thus, it is critical to determine whether MYC protein is elevated in human prostate cancer, and if so, at what stage of the disease this elevation occurs. Prior studies of MYC protein localization have been hampered by lack of suitable antibodies and controls. We utilized a new anti-MYC antibody coupled with genetically defined control experiments to localize MYC protein within human tissue microarrays consisting of normal, atrophy, PIN, primary adenocarcinoma, and metastatic adenocarcinoma. Nuclear overexpression of MYC protein occurred frequently in luminal cells of PIN, as well as in most primary carcinomas and metastatic disease. MYC protein did not correlate with gain of 8q24, suggesting alternative mechanisms for MYC overexpression. These results provide evidence that upregulation of nuclear MYC protein expression is a highly prevalent and early change in prostate cancer and suggest that increased nuclear MYC may be a critical oncogenic event driving human prostate cancer initiation and progression.

KW - MYC oncoprotein

KW - Prostatic carcinoma

KW - Prostatic intraepithelial neoplasia

UR - http://www.scopus.com/inward/record.url?scp=50249133616&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=50249133616&partnerID=8YFLogxK

U2 - 10.1038/modpathol.2008.111

DO - 10.1038/modpathol.2008.111

M3 - Article

VL - 21

SP - 1156

EP - 1167

JO - Modern Pathology

JF - Modern Pathology

SN - 0893-3952

IS - 9

ER -